Nutraceuticals show promising results for hair growth in women
We sat down with Glynis Ablon, MD, FAAD to learn about her research on nutraceuticals for hair growth in midlife.
Roughly 40% of women over 60 will experience female pattern hair loss, or androgenetic alopecia. However, new research from the University of California, Los Angeles, suggests nutraceuticals may be the key to hair growth in menopausal women.
Although there are several Food and Drug Administration (FDA)-approved drugs for male and female pattern hair loss, many women prefer more natural medications. The new study suggests that a nutraceutical supplement with nutrient-derived bioactive compounds may promote hair growth in perimenopausal, menopausal, and postmenopausal women.
Hear the perspective of lead author Glynis Ablon of the Ablon Skin Institute and Research Center in California, in the video above.
References
- Ablon G. Nutraceuticals. Dermatologic Clinics. 2021;39(3):417-427. doi:10.1016/j.det.2021.03.006
- Nutraceuticals May Be the Secret to a Full Head of Hair for Women at Midlife. Accessed September 24, 2021. https://www.menopause.org/docs/default-source/press-release/nutraceutical-supplement-for-promoting-hair-growth.pdf
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person
December 3rd 2021In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.
Listen
Study links premature menopause to musculoskeletal pain and sarcopenia risks
May 1st 2024A recent study revealed an association between premature menopause and increased risks of musculoskeletal pain and sarcopenia, emphasizing the potential benefits of hormone therapy in mitigating long-term effects.
Read More
